Skip to content

Study · Measured the body's own peptide · 1989

1 result

Localization of immunoreactive thymosin alpha 1 in astrocytes of normal human brain.

Su YL, Ho KL, Dalakas MC, Mutchnick MG

Annals of neurology1 Aug 1989Cited by 20 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelEx vivo tissueOther

    In sections of normal human brain, antiserum to thymosin alpha‑1 stained the cell body but not the processes of GFAP-positive astrocytes.

    In plain wordsIn lab tests of human brain tissue, the body's own thymosin alpha‑1 was found inside the cell bodies of astrocytes.

    Outcome
    Not applicableImmunoreactive thymosin alpha 1 in astrocytes
    Study

    humann: not reported in source

    Normal human brain tissue sections
    Outcome group
    Endogenous peptide levels · Nervous system and cognition

    Source sentences

    Summary
    Antiserum to T alpha 1 stained the cell body, but not the processes, of GFAP-positive astrocytes, suggesting that T alpha 1 is a common antigen shared between thymus and astrocytes.
    1 context sentence
    Summary · context
    We employed an immunocytochemical method to examine human brain for the presence of immunoreactive thymosin alpha 1 (T alpha 1), a peptide derivative of thymic tissue, using a well-characterized antiserum.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 4Current

    12 Oct 2026, 18:17 UTC

    Study data updated · source update from Europe PMC

  2. Version 3

    10 Oct 2026, 08:55 UTC

    Study results updated

  3. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  4. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.